Clinical trial
Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
NCT00001550 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001550 |
|---|---|
| Title | Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) |
| Official title | The Efficacy of High-Dose Intravenous Immunoglobulin Therapy in Patients With Stiff-Man Syndrome: A Double-Blind, Placebo-Controlled Trial |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Muscle Rigidity, Spasm, Stiff Man Syndrome |
| Intervention type | Drug |
| Interventions | IVIg |
| Enrollment | 20 |
| Start date | Apr 1, 1996 |
| Completion | May 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 14, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: